Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrique Alvarez

Showing results (81-90 of 247) with videos related to

Pageof 25
Sort By:
Clinical Practice and Epidemiology in Mental Health : CP & EMH|November 23, 2012
Broadening of Generalized Anxiety Disorders Definition Does not Affect the Response to Psychiatric Care: Findings from the Observational ADAN StudyEnrique Alvarez, Jose L Carrasco, José M Olivares, et al.
IEEE Journal of Solid-State Circuits|December 19, 2018
High-Density Redox Amplified Coulostatic Discharge-Based Biosensor ArrayAlexander C Sun, Enrique Alvarez-Fontecilla, A G Venkatesh, et al.
Annals of Clinical and Translational Neurology|August 9, 2020
Serious safety events in rituximab-treated multiple sclerosis and related disordersBrandi L Vollmer, Asya I Wallach, John R Corboy, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 26, 2019
Subjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumesIsaiah Kletenik, Enrique Alvarez, Justin M Honce, et al.
Annals of Clinical and Translational Neurology|March 9, 2019
Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatmentBrandi L Vollmer, Kavita V Nair, Stefan Sillau, et al.
International Clinical Psychopharmacology|September 15, 2010
A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelinesJuan C Pascual, Ana Martín-Blanco, Joaquim Soler, et al.
Journal of the Neurological Sciences|May 27, 2018
The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosisBrandi Vollmer, Justin M Honce, Stefan Sillau, et al.
Plos One|December 4, 2009
HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavageAlfredo Castelló, David Franco, Pablo Moral-López, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 30, 2012
Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in SpainMarina De Salas-Cansado, José M Olivares, Enrique Alvarez, et al.
Neurorehabilitation and Neural Repair|January 26, 2018
Pulse Width Does Not Influence the Gains Achieved With Neuromuscular Electrical Stimulation in People With Multiple Sclerosis: Double-Blind, Randomized TrialAwad M Almuklass, Leah Davis, Landon D Hamilton, et al.
Pageof 25

Showing results (81-90 of 247) with videos related to

Sort By:
Pageof 25
Clinical Practice and Epidemiology in Mental Health : CP & EMH|November 23, 2012
Broadening of Generalized Anxiety Disorders Definition Does not Affect the Response to Psychiatric Care: Findings from the Observational ADAN StudyEnrique Alvarez, Jose L Carrasco, José M Olivares, et al.
IEEE Journal of Solid-State Circuits|December 19, 2018
High-Density Redox Amplified Coulostatic Discharge-Based Biosensor ArrayAlexander C Sun, Enrique Alvarez-Fontecilla, A G Venkatesh, et al.
Annals of Clinical and Translational Neurology|August 9, 2020
Serious safety events in rituximab-treated multiple sclerosis and related disordersBrandi L Vollmer, Asya I Wallach, John R Corboy, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 26, 2019
Subjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumesIsaiah Kletenik, Enrique Alvarez, Justin M Honce, et al.
Annals of Clinical and Translational Neurology|March 9, 2019
Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatmentBrandi L Vollmer, Kavita V Nair, Stefan Sillau, et al.
International Clinical Psychopharmacology|September 15, 2010
A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelinesJuan C Pascual, Ana Martín-Blanco, Joaquim Soler, et al.
Journal of the Neurological Sciences|May 27, 2018
The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosisBrandi Vollmer, Justin M Honce, Stefan Sillau, et al.
Plos One|December 4, 2009
HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavageAlfredo Castelló, David Franco, Pablo Moral-López, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 30, 2012
Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in SpainMarina De Salas-Cansado, José M Olivares, Enrique Alvarez, et al.
Neurorehabilitation and Neural Repair|January 26, 2018
Pulse Width Does Not Influence the Gains Achieved With Neuromuscular Electrical Stimulation in People With Multiple Sclerosis: Double-Blind, Randomized TrialAwad M Almuklass, Leah Davis, Landon D Hamilton, et al.
Pageof 25